Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: Vet Ophthalmol. 2011 Apr 18;14(5):304–312. doi: 10.1111/j.1463-5224.2011.00877.x

Figure 4.

Figure 4

Immunofluorescence studies demonstrating F-actin expression. Compared to the untreated controls (a, c), the 0.02% mitomycin C (MMC) treatment to canine corneal fibroblast (b) and myofibroblast cells (d) significantly reduced expression of F-actin (51–59%; P < 0.01) as per digital quantification. The arrows indicate F-actin positive cells. Nuclei are stained blue with DAPI; scale bar denotes 100 µm.